DE69924262D1 - Verfahren zur herstellung von durch hefe exprimierte hpv typs 6 und 16 kapsid-proteinen - Google Patents
Verfahren zur herstellung von durch hefe exprimierte hpv typs 6 und 16 kapsid-proteinenInfo
- Publication number
- DE69924262D1 DE69924262D1 DE69924262T DE69924262T DE69924262D1 DE 69924262 D1 DE69924262 D1 DE 69924262D1 DE 69924262 T DE69924262 T DE 69924262T DE 69924262 T DE69924262 T DE 69924262T DE 69924262 D1 DE69924262 D1 DE 69924262D1
- Authority
- DE
- Germany
- Prior art keywords
- proteins
- production
- kapsid
- typs
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 2
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 2
- 241000341655 Human papillomavirus type 16 Species 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9662598P | 1998-08-14 | 1998-08-14 | |
US96625P | 1998-08-14 | ||
PCT/US1999/018016 WO2000009699A2 (en) | 1998-08-14 | 1999-08-13 | Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69924262D1 true DE69924262D1 (de) | 2005-04-21 |
DE69924262T2 DE69924262T2 (de) | 2006-01-26 |
DE69924262T3 DE69924262T3 (de) | 2009-07-23 |
Family
ID=22258285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69924262T Expired - Lifetime DE69924262T3 (de) | 1998-08-14 | 1999-08-13 | Verfahren zur herstellung von durch hefe exprimierte hpv typs 6 und 16 kapsid-proteinen |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1105495B2 (de) |
AT (1) | ATE291089T1 (de) |
CA (1) | CA2340422C (de) |
DE (1) | DE69924262T3 (de) |
WO (1) | WO2000009699A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206359D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
US7858098B2 (en) | 2002-12-20 | 2010-12-28 | Glaxosmithkline Biologicals, S.A. | Vaccine |
US7758866B2 (en) | 2004-06-16 | 2010-07-20 | Glaxosmithkline Biologicals, S.A. | Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52 |
CN101180312A (zh) | 2005-02-18 | 2008-05-14 | 诺华疫苗和诊断公司 | 来自尿路病原性大肠杆菌的免疫原 |
WO2006089264A2 (en) | 2005-02-18 | 2006-08-24 | Novartis Vaccines And Diagnostics Inc. | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
EP1877087B1 (de) | 2005-04-15 | 2013-02-20 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Verfahren und zusammensetzungen zur erzeugung einer verbesserten immunantwort auf ein menschliches papillomavirus-immunogen |
JP5215865B2 (ja) | 2005-11-22 | 2013-06-19 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド | ノロウイルス抗原およびサポウイルス抗原 |
US20100166788A1 (en) | 2006-08-16 | 2010-07-01 | Novartis Vaccines And Diagnostics | Immunogens from uropathogenic escherichia coli |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT402898B (de) * | 1994-08-08 | 1997-09-25 | Int Centre Genetic Eng & Bio | Molekulares präsentiersystem |
CA2267639C (en) * | 1996-10-04 | 2005-11-22 | Merck & Co., Inc. | Synthetic hpv16 virus-like particles |
-
1999
- 1999-08-13 WO PCT/US1999/018016 patent/WO2000009699A2/en active IP Right Grant
- 1999-08-13 CA CA2340422A patent/CA2340422C/en not_active Expired - Fee Related
- 1999-08-13 EP EP99940986A patent/EP1105495B2/de not_active Expired - Lifetime
- 1999-08-13 DE DE69924262T patent/DE69924262T3/de not_active Expired - Lifetime
- 1999-08-13 AT AT99940986T patent/ATE291089T1/de active
Also Published As
Publication number | Publication date |
---|---|
DE69924262T3 (de) | 2009-07-23 |
CA2340422A1 (en) | 2000-02-24 |
DE69924262T2 (de) | 2006-01-26 |
EP1105495A2 (de) | 2001-06-13 |
EP1105495B2 (de) | 2009-01-21 |
EP1105495B1 (de) | 2005-03-16 |
WO2000009699A9 (en) | 2000-07-27 |
ATE291089T1 (de) | 2005-04-15 |
CA2340422C (en) | 2010-03-16 |
WO2000009699A3 (en) | 2000-05-18 |
WO2000009699A2 (en) | 2000-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR15C0079I2 (fr) | Expression optimisee de hpv 31 l1 dans la levure | |
DE59402827D1 (de) | Verfahren zur gewinnung nativer, oligomerer, glykosylierter ektodomänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv | |
HUP9903829A1 (hu) | RNS-vírusok fertőző klónjai,belőlük kifejlesztett vakcinák és diagnosztikai eljárások | |
AR039005A1 (es) | Antigenos virales | |
WO2003078455A3 (en) | Virus like particle from papillomavirus and their use in vaccine | |
DE69924262D1 (de) | Verfahren zur herstellung von durch hefe exprimierte hpv typs 6 und 16 kapsid-proteinen | |
EP1687329B8 (de) | Optimierte expression von hpv-58-l1 in hefe | |
MY148656A (en) | Optimized expression of hpv 52 l1 in yeast. | |
FR11C0022I2 (fr) | Production de proteine de capside de virus du papillome humain et particules de type viral | |
YU37502A (sh) | Infektivni klonovi | |
ATE369428T1 (de) | Behandlung von gebärmutterhalskrebs | |
WO1999061052A3 (en) | Oral immunization with papillomavirus virus-like particles | |
RU97110164A (ru) | Очищенные белки вируса папилломы | |
WO1997004099A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen | |
DK0750669T3 (da) | Modificeret papillomavirus-L2-protein og VLP'er dannet derudfra | |
ATE345814T1 (de) | Herstellung eines chimeren papillomavirus | |
WO2005090584A3 (de) | Impfstoff gegen influenza basierend auf geflügelpestviren | |
DE59812566D1 (de) | Verfahren zur gewinnung von virusähnlichen partikeln auf der basis von polyomaviren | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
JP2002509863A5 (de) | ||
WO2002055542A3 (de) | Hpv-spezifische peptide, die die bindung von hpv an die wirtszelle blockieren | |
WO2000014112A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen | |
Jin et al. | Biofilm-forming ability of Candida albicans is unlikely to contribute to high oral yeast carriage in human immunodeficiency virus infection | |
WO1998001570A3 (en) | Mutated antibody-dependent infection enhancing domains of hiv | |
AU2001270226A1 (en) | Tolerance and chronic hepatitis c virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS,INC.(N.D.GES, US |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., EMERY, US |